224 related articles for article (PubMed ID: 24079660)
1. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
[TBL] [Abstract][Full Text] [Related]
2. Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
Prezioso C; Zingaropoli MA; Iannetta M; Rodio DM; Altieri M; Conte A; Vullo V; Ciardi MR; Palamara AT; Pietropaolo V
Mult Scler Relat Disord; 2020 Jun; 41():102008. PubMed ID: 32087593
[TBL] [Abstract][Full Text] [Related]
3. Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
Pietropaolo V; Bellizzi A; Anzivino E; Iannetta M; Zingaropoli MA; Rodio DM; Morreale M; Pontecorvo S; Francia A; Vullo V; Palamara AT; Ciardi MR
J Neurovirol; 2015 Dec; 21(6):653-65. PubMed ID: 25930159
[TBL] [Abstract][Full Text] [Related]
4. Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab.
Bellizzi A; Anzivino E; Ferrari F; Di Nardo G; Colosimo MT; Fioriti D; Mischitelli M; Chiarini F; Cucchiara S; Pietropaolo V
J Neurovirol; 2011 Aug; 17(4):303-13. PubMed ID: 21547609
[TBL] [Abstract][Full Text] [Related]
5. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
[TBL] [Abstract][Full Text] [Related]
6. Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study.
Rodio DM; Anzivino E; Mischitelli M; Bellizzi A; Scrivo R; Scribano D; Conte G; Prezioso C; Trancassini M; Valesini G; Palamara AT; Pietropaolo V
Front Microbiol; 2016; 7():672. PubMed ID: 27242700
[TBL] [Abstract][Full Text] [Related]
7. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.
Ciardi MR; Zingaropoli MA; Iannetta M; Prezioso C; Perri V; Pasculli P; Lichtner M; d'Ettorre G; Altieri M; Conte A; Pietropaolo V; Mastroianni CM; Vullo V
Virol J; 2020 Feb; 17(1):23. PubMed ID: 32046748
[TBL] [Abstract][Full Text] [Related]
8. Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection.
Prezioso C; Scribano D; Bellizzi A; Anzivino E; Rodio DM; Trancassini M; Palamara AT; Pietropaolo V
Arch Virol; 2017 Dec; 162(12):3745-3752. PubMed ID: 28884263
[TBL] [Abstract][Full Text] [Related]
9. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
10. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
[TBL] [Abstract][Full Text] [Related]
11. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Chen Y; Bord E; Tompkins T; Miller J; Tan CS; Kinkel RP; Stein MC; Viscidi RP; Ngo LH; Koralnik IJ
N Engl J Med; 2009 Sep; 361(11):1067-74. PubMed ID: 19741227
[TBL] [Abstract][Full Text] [Related]
13. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
14. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.
Gosert R; Kardas P; Major EO; Hirsch HH
J Virol; 2010 Oct; 84(20):10448-56. PubMed ID: 20686041
[TBL] [Abstract][Full Text] [Related]
15. JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence.
Prezioso C; Pietropaolo V; Moens U; Ciotti M
Expert Rev Mol Diagn; 2023 Feb; 23(2):143-157. PubMed ID: 36786077
[TBL] [Abstract][Full Text] [Related]
16. The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.
Rocca A; Martelli F; Delbue S; Ferrante P; Bartolozzi D; Azzi A; Giannecchini S
J Clin Virol; 2015 Sep; 70():1-6. PubMed ID: 26305810
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A
Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083
[TBL] [Abstract][Full Text] [Related]
18. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
19. Archetype JC Polyomavirus (JCPyV) Prevails in a Rare Case of JCPyV Nephropathy and in Stable Renal Transplant Recipients With JCPyV Viruria.
Seppälä HM; Helanterä IT; Laine PKS; Lautenschlager IT; Paulín LG; Jahnukainen TJ; Auvinen POV; Auvinen E
J Infect Dis; 2017 Nov; 216(8):981-989. PubMed ID: 28968776
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing.
Auvinen E; Honkimaa A; Laine P; Passerini S; Moens U; Pietropaolo V; Saarela M; Maunula L; Mannonen L; Tynninen O; Haapasalo H; Rauramaa T; Auvinen P; Liimatainen H
J Clin Virol; 2024 Apr; 171():105652. PubMed ID: 38364704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
